These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 17147006)

  • 21. Endoscopy for upper GI cancer screening in the general population: a cost-utility analysis.
    Gupta N; Bansal A; Wani SB; Gaddam S; Rastogi A; Sharma P
    Gastrointest Endosc; 2011 Sep; 74(3):610-624.e2. PubMed ID: 21741639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An economic evaluation of an abdominal aortic aneurysm screening program in Italy.
    Giardina S; Pane B; Spinella G; Cafueri G; Corbo M; Brasseur P; Orengo G; Palombo D
    J Vasc Surg; 2011 Oct; 54(4):938-46. PubMed ID: 21820837
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening and prevention of venous thromboembolism in critically ill patients: a decision analysis and economic evaluation.
    Sud S; Mittmann N; Cook DJ; Geerts W; Chan B; Dodek P; Gould MK; Guyatt G; Arabi Y; Fowler RA; ;
    Am J Respir Crit Care Med; 2011 Dec; 184(11):1289-98. PubMed ID: 21868500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.
    Main C; Bojke L; Griffin S; Norman G; Barbieri M; Mather L; Stark D; Palmer S; Riemsma R
    Health Technol Assess; 2006 Mar; 10(9):1-132. iii-iv. PubMed ID: 16545208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The cost-effectiveness of expanding newborn screening for up to 21 inherited metabolic disorders using tandem mass spectrometry: results from a decision-analytic model.
    Cipriano LE; Rupar CA; Zaric GS
    Value Health; 2007; 10(2):83-97. PubMed ID: 17391418
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A computer simulation model for cost-effectiveness analysis of mass screening for Type 2 diabetes mellitus.
    Chen TH; Yen MF; Tung TH
    Diabetes Res Clin Pract; 2001 Nov; 54 Suppl 1():S37-42. PubMed ID: 11580967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The cost-effectiveness of screening for oral cancer in primary care.
    Speight PM; Palmer S; Moles DR; Downer MC; Smith DH; Henriksson M; Augustovski F
    Health Technol Assess; 2006 Apr; 10(14):1-144, iii-iv. PubMed ID: 16707071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness of screening for HIV in the era of highly active antiretroviral therapy.
    Sanders GD; Bayoumi AM; Sundaram V; Bilir SP; Neukermans CP; Rydzak CE; Douglass LR; Lazzeroni LC; Holodniy M; Owens DK
    N Engl J Med; 2005 Feb; 352(6):570-85. PubMed ID: 15703422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness of screening for anal squamous intraepithelial lesions and anal cancer in human immunodeficiency virus-negative homosexual and bisexual men.
    Goldie SJ; Kuntz KM; Weinstein MC; Freedberg KA; Palefsky JM
    Am J Med; 2000 Jun; 108(8):634-41. PubMed ID: 10856411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimal screening strategy for familial intracranial aneurysms: a cost-effectiveness analysis.
    Bor AS; Koffijberg H; Wermer MJ; Rinkel GJ
    Neurology; 2010 May; 74(21):1671-9. PubMed ID: 20498435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-Effectiveness of Screening for Intermediate Age-Related Macular Degeneration during Diabetic Retinopathy Screening.
    Chan CK; Gangwani RA; McGhee SM; Lian J; Wong DS
    Ophthalmology; 2015 Nov; 122(11):2278-85. PubMed ID: 26315045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A cost-effectiveness analysis of adding a human papillomavirus vaccine to the Australian National Cervical Cancer Screening Program.
    Kulasingam S; Connelly L; Conway E; Hocking JS; Myers E; Regan DG; Roder D; Ross J; Wain G
    Sex Health; 2007 Sep; 4(3):165-75. PubMed ID: 17931529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness and cost-utility of population-based glaucoma screening in China: a decision-analytic Markov model.
    Tang J; Liang Y; O'Neill C; Kee F; Jiang J; Congdon N
    Lancet Glob Health; 2019 Jul; 7(7):e968-e978. PubMed ID: 31122906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The cost-effectiveness of screening strategies for familial hypercholesterolaemia in Poland.
    Pelczarska A; Jakubczyk M; Jakubiak-Lasocka J; Banach M; Myśliwiec M; Gruchała M; Niewada M
    Atherosclerosis; 2018 Mar; 270():132-138. PubMed ID: 29407882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening for latent and active tuberculosis infection in the elderly at admission to residential care homes: A cost-effectiveness analysis in an intermediate disease burden area.
    Li J; Yip BHK; Leung C; Chung W; Kwok KO; Chan EYY; Yeoh E; Chung P
    PLoS One; 2018; 13(1):e0189531. PubMed ID: 29293514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gastric adenocarcinoma screening and prevention in the era of new biomarker and endoscopic technologies: a cost-effectiveness analysis.
    Yeh JM; Hur C; Ward Z; Schrag D; Goldie SJ
    Gut; 2016 Apr; 65(4):563-74. PubMed ID: 25779597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cost-effectiveness of depression screening for the general adult population.
    Yildirim M; Gaynes BN; Keskinocak P; Pence BW; Swann J
    J Affect Disord; 2022 Apr; 303():306-314. PubMed ID: 35181387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness of treating normal tension glaucoma.
    Li EY; Tham CC; Chi SC; Lam DS
    Invest Ophthalmol Vis Sci; 2013 May; 54(5):3394-9. PubMed ID: 23599342
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The cost-utility of telemedicine to screen for diabetic retinopathy in India.
    Rachapelle S; Legood R; Alavi Y; Lindfield R; Sharma T; Kuper H; Polack S
    Ophthalmology; 2013 Mar; 120(3):566-573. PubMed ID: 23211635
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness of Chagas disease screening in Latin American migrants at primary health-care centres in Europe: a Markov model analysis.
    Requena-Méndez A; Bussion S; Aldasoro E; Jackson Y; Angheben A; Moore D; Pinazo MJ; Gascón J; Muñoz J; Sicuri E
    Lancet Glob Health; 2017 Apr; 5(4):e439-e447. PubMed ID: 28256340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.